IRONWOOD PHARMACEUTICALS, INC. Stock-Based Compensation
IRONWOOD PHARMACEUTICALS, INC. (IRWD) reported Stock-Based Compensation of $6.89 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-06
- IRONWOOD PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $3.24M, a 28.47% decline year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $3.65M, a 30.96% decline year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $3.82M, a 16.27% decline year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $3.61M, a 56.63% decline year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $17.25M, a 42.21% decline from fiscal 2024.
- IRONWOOD PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $29.85M, a 6.73% decline from fiscal 2023.
- IRONWOOD PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $32.01M, a 18.33% increase from fiscal 2022.
- IRONWOOD PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $27.05M, a 21.39% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $6.89M 10-Q · filed 2026-08-06 | $10.71M derived: sum of 3 quarters · filed 2026-08-06 | $14.32M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $3.65M 10-Q · filed 2026-05-07 | $7.48M derived: sum of 2 quarters · filed 2026-05-07 | $11.09M derived: sum of 3 quarters · filed 2026-05-07 | $15.61M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $3.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $7.43M derived: sum of 2 quarters · filed 2026-02-26 | $11.96M derived: sum of 3 quarters · filed 2026-08-06 | $17.25M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $3.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $8.14M derived: sum of 2 quarters · filed 2026-08-06 | $13.43M 10-Q · filed 2025-11-10 | $17.99M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $4.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $9.81M 10-Q · filed 2026-08-06 | $14.38M derived: sum of 3 quarters · filed 2026-08-06 | $22.71M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $5.29M 10-Q · filed 2026-05-07 | $9.86M derived: sum of 2 quarters · filed 2026-05-07 | $18.19M derived: sum of 3 quarters · filed 2026-05-07 | $26.76M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $4.57M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $12.89M derived: sum of 2 quarters · filed 2026-02-26 | $21.46M derived: sum of 3 quarters · filed 2026-02-26 | $29.85M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $8.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $16.90M derived: sum of 2 quarters · filed 2025-11-10 | $25.28M 10-Q · filed 2025-11-10 | $33.99M derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | $8.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $16.95M 10-Q · filed 2025-08-11 | $25.66M derived: sum of 3 quarters · filed 2025-08-11 | $33.56M derived: sum of 4 quarters · filed 2025-08-11 | ||||
| 2024-03-31 | $8.38M 10-Q · filed 2025-05-12 | $17.09M derived: sum of 2 quarters · filed 2025-05-12 | $25.00M derived: sum of 3 quarters · filed 2025-05-12 | $33.26M derived: sum of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | $8.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $16.61M derived: sum of 2 quarters · filed 2025-03-31 | $24.87M derived: sum of 3 quarters · filed 2025-03-31 | $32.01M 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $7.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $16.17M derived: sum of 2 quarters · filed 2024-11-07 | $23.30M 10-Q · filed 2024-11-07 | $30.59M derived: sum of 4 quarters · filed 2025-03-31 | ||||
| 2023-06-30 | $8.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $15.39M 10-Q · filed 2024-08-08 | $22.69M derived: sum of 3 quarters · filed 2025-03-31 | $29.75M derived: sum of 4 quarters · filed 2025-03-31 | ||||
| 2023-03-31 | $7.13M 10-Q · filed 2024-05-09 | $14.42M derived: sum of 2 quarters · filed 2025-03-31 | $21.49M derived: sum of 3 quarters · filed 2025-03-31 | $28.09M derived: sum of 4 quarters · filed 2025-03-31 | ||||
| 2022-12-31 | $7.29M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $14.36M derived: sum of 2 quarters · filed 2025-03-31 | $20.96M derived: sum of 3 quarters · filed 2025-03-31 | $27.05M 10-K · filed 2025-03-31 | ||||
| 2022-09-30 | $7.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $13.67M derived: sum of 2 quarters · filed 2023-11-09 | $19.76M 10-Q · filed 2023-11-09 | $25.85M derived: sum of 4 quarters · filed 2024-02-16 | ||||
| 2022-06-30 | $6.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $12.69M 10-Q · filed 2023-08-09 | $18.78M derived: sum of 3 quarters · filed 2024-02-16 | $24.99M derived: sum of 4 quarters · filed 2024-02-16 | ||||
| 2022-03-31 | $6.09M 10-Q · filed 2023-05-04 | $12.18M derived: sum of 2 quarters · filed 2024-02-16 | $18.39M derived: sum of 3 quarters · filed 2024-02-16 | $22.97M derived: sum of 4 quarters · filed 2024-02-16 | ||||
| 2021-12-31 | $6.09M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16 | $12.30M derived: sum of 2 quarters · filed 2024-02-16 | $16.89M derived: sum of 3 quarters · filed 2024-02-16 | $22.28M 10-K · filed 2024-02-16 | ||||
| 2021-09-30 | $6.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $10.79M derived: sum of 2 quarters · filed 2022-11-03 | $16.19M 10-Q · filed 2022-11-03 | $26.20M derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2021-06-30 | $4.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $9.98M 10-Q · filed 2022-08-04 | $19.99M derived: sum of 3 quarters · filed 2023-02-16 | $27.70M derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2021-03-31 | $5.40M 10-Q · filed 2022-05-05 | $15.40M derived: sum of 2 quarters · filed 2023-02-16 | $23.12M derived: sum of 3 quarters · filed 2023-02-16 | $30.21M derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2020-12-31 | $10.01M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $17.72M derived: sum of 2 quarters · filed 2023-02-16 | $24.81M derived: sum of 3 quarters · filed 2023-02-16 | $31.18M 10-K · filed 2023-02-16 | ||||
| 2020-09-30 | $7.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $14.80M derived: sum of 2 quarters · filed 2021-11-04 | $21.17M 10-Q · filed 2021-11-04 | $26.65M derived: sum of 4 quarters · filed 2022-02-18 | ||||
| 2020-06-30 | $7.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $13.46M 10-Q · filed 2021-08-05 | $18.94M derived: sum of 3 quarters · filed 2022-02-18 | $24.46M derived: sum of 4 quarters · filed 2022-02-18 | ||||
| 2020-03-31 | $6.36M 10-Q · filed 2021-05-06 | $11.85M derived: sum of 2 quarters · filed 2022-02-18 | $17.37M derived: sum of 3 quarters · filed 2022-02-18 | $23.71M derived: sum of 4 quarters · filed 2022-02-18 | ||||
| 2019-12-31 | $5.49M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | $11.01M derived: sum of 2 quarters · filed 2022-02-18 | $17.34M derived: sum of 3 quarters · filed 2022-02-18 | $31.28M 10-K · filed 2022-02-18 | ||||
| 2019-09-30 | $5.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $11.86M derived: sum of 2 quarters · filed 2020-11-05 | $25.79M 10-Q · filed 2020-11-05 | $36.15M derived: sum of 4 quarters · filed 2021-02-17 | ||||
| 2019-06-30 | $6.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $20.27M 10-Q · filed 2020-08-06 | $30.63M derived: sum of 3 quarters · filed 2021-02-17 | $42.74M derived: sum of 4 quarters · filed 2021-02-17 | ||||
| 2019-03-31 | $13.93M 10-Q · filed 2020-05-06 | $14.99M 10-Q · filed 2019-05-02 | $24.30M derived: sum of 2 quarters · filed 2021-02-17 | $36.41M derived: sum of 3 quarters · filed 2021-02-17 | $45.42M derived: sum of 4 quarters · filed 2021-02-17 | |||
| 2018-12-31 | $10.36M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | $22.47M derived: sum of 2 quarters · filed 2021-02-17 | $31.48M derived: sum of 3 quarters · filed 2021-02-17 | $40.53M 10-K · filed 2021-02-17 | $43.98M 10-K · filed 2019-02-25 | |||
| 2018-09-30 | $12.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $21.12M derived: sum of 2 quarters · filed 2019-10-31 | $30.16M 10-Q · filed 2019-10-31 | $32.76M 10-Q · filed 2018-11-06 | $35.95M derived: sum of 4 quarters · filed 2020-02-13 | |||
| 2018-06-30 | $9.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-30 | $18.05M 10-Q · filed 2019-07-30 | $19.79M 10-Q · filed 2018-08-06 | $23.84M derived: sum of 3 quarters · filed 2020-02-13 | $32.54M derived: sum of 4 quarters · filed 2020-02-13 | |||
| 2018-03-31 | $9.04M 10-Q · filed 2019-05-02 | $14.83M derived: sum of 2 quarters · filed 2020-02-13 | $23.53M derived: sum of 3 quarters · filed 2020-02-13 | $32.67M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2017-12-31 | $5.79M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $14.49M derived: sum of 2 quarters · filed 2020-02-13 | $23.63M derived: sum of 3 quarters · filed 2020-02-13 | $30.91M 10-K · filed 2020-02-13 | $33.82M 10-K · filed 2018-02-22 | |||
| 2017-09-30 | $8.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $17.84M derived: sum of 2 quarters · filed 2018-11-06 | $25.12M 10-Q · filed 2018-11-06 | $32.50M derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2017-06-30 | $9.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $16.42M 10-Q · filed 2018-08-06 | $23.80M derived: sum of 3 quarters · filed 2019-02-25 | $30.73M derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2017-03-31 | $7.28M 10-Q · filed 2018-05-04 | $14.66M derived: sum of 2 quarters · filed 2019-02-25 | $21.59M derived: sum of 3 quarters · filed 2019-02-25 | $29.69M derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2016-12-31 | $7.38M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $14.32M derived: sum of 2 quarters · filed 2019-02-25 | $22.41M derived: sum of 3 quarters · filed 2019-02-25 | $29.22M 10-K · filed 2019-02-25 | ||||
| 2016-09-30 | $6.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $15.03M derived: sum of 2 quarters · filed 2017-11-02 | $21.84M 10-Q · filed 2017-11-02 | $28.34M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2016-06-30 | $8.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $14.90M 10-Q · filed 2017-08-03 | $21.40M derived: sum of 3 quarters · filed 2018-02-22 | $28.04M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2016-03-31 | $6.81M 10-Q · filed 2017-05-08 | $13.31M derived: sum of 2 quarters · filed 2018-02-22 | $19.95M derived: sum of 3 quarters · filed 2018-02-22 | $26.85M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2015-12-31 | $6.50M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $13.14M derived: sum of 2 quarters · filed 2018-02-22 | $20.04M derived: sum of 3 quarters · filed 2018-02-22 | $25.47M 10-K · filed 2018-02-22 | ||||
| 2015-09-30 | $6.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $13.54M derived: sum of 2 quarters · filed 2016-11-07 | $18.97M 10-Q · filed 2016-11-07 | $27.53M derived: sum of 4 quarters · filed 2017-02-22 | ||||
| 2015-06-30 | $6.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $12.33M 10-Q · filed 2016-08-08 | $20.89M derived: sum of 3 quarters · filed 2017-02-22 | $26.43M derived: sum of 4 quarters · filed 2017-02-22 | ||||
| 2015-03-31 | $5.43M 10-Q · filed 2016-05-10 | $13.99M derived: sum of 2 quarters · filed 2017-02-22 | $19.52M derived: sum of 3 quarters · filed 2017-02-22 | $25.54M derived: sum of 4 quarters · filed 2017-02-22 | ||||
| 2014-12-31 | $8.56M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | $14.10M derived: sum of 2 quarters · filed 2017-02-22 | $20.11M derived: sum of 3 quarters · filed 2017-02-22 | $26.18M 10-K · filed 2017-02-22 | ||||
| 2014-09-30 | $5.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $11.55M derived: sum of 2 quarters · filed 2015-11-05 | $17.62M 10-Q · filed 2015-11-05 | $22.16M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-06-30 | $6.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $12.09M 10-Q · filed 2015-08-07 | $16.62M derived: sum of 3 quarters · filed 2016-02-19 | $21.82M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-03-31 | $6.07M 10-Q · filed 2015-05-06 | $10.61M derived: sum of 2 quarters · filed 2016-02-19 | $15.81M derived: sum of 3 quarters · filed 2016-02-19 | $20.63M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2013-12-31 | $4.54M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $9.74M derived: sum of 2 quarters · filed 2016-02-19 | $14.55M derived: sum of 3 quarters · filed 2016-02-19 | $19.83M 10-K · filed 2016-02-19 | ||||
| 2013-09-30 | $5.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | $10.02M derived: sum of 2 quarters · filed 2014-11-05 | $15.29M 10-Q · filed 2014-11-05 | $19.95M derived: sum of 4 quarters · filed 2015-02-18 | ||||
| 2013-06-30 | $4.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $10.09M 10-Q · filed 2014-08-05 | $14.75M derived: sum of 3 quarters · filed 2015-02-18 | $19.89M derived: sum of 4 quarters · filed 2015-02-18 | ||||
| 2013-03-31 | $5.28M 10-Q · filed 2014-04-29 | $9.94M derived: sum of 2 quarters · filed 2015-02-18 | $15.07M derived: sum of 3 quarters · filed 2015-02-18 | $19.13M derived: sum of 4 quarters · filed 2015-02-18 | ||||
| 2012-12-31 | $4.66M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-18 | $9.80M derived: sum of 2 quarters · filed 2015-02-18 | $13.85M derived: sum of 3 quarters · filed 2015-02-18 | $17.57M 10-K · filed 2015-02-18 | ||||
| 2012-09-30 | $5.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28 | $9.19M derived: sum of 2 quarters · filed 2013-10-28 | $12.91M 10-Q · filed 2013-10-28 | $16.13M derived: sum of 4 quarters · filed 2014-02-07 | ||||
| 2012-06-30 | $4.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $7.78M 10-Q · filed 2013-08-08 | $11.00M derived: sum of 3 quarters · filed 2014-02-07 | $13.86M derived: sum of 4 quarters · filed 2014-02-07 | ||||
| 2012-03-31 | $3.72M 10-Q · filed 2013-04-23 | $6.94M derived: sum of 2 quarters · filed 2014-02-07 | $9.80M derived: sum of 3 quarters · filed 2014-02-07 | $12.76M derived: sum of 4 quarters · filed 2014-02-07 | ||||
| 2011-12-31 | $3.22M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-07 | $6.08M derived: sum of 2 quarters · filed 2014-02-07 | $9.03M derived: sum of 3 quarters · filed 2014-02-07 | $11.73M 10-K · filed 2014-02-07 | ||||
| 2011-09-30 | $2.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $5.81M derived: sum of 2 quarters · filed 2012-11-06 | $8.51M 10-Q · filed 2012-11-06 | $10.87M derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2011-06-30 | $2.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $5.65M 10-Q · filed 2012-08-07 | $8.01M derived: sum of 3 quarters · filed 2013-02-21 | $9.89M derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2011-03-31 | $2.70M 10-Q · filed 2012-05-10 | $5.06M derived: sum of 2 quarters · filed 2013-02-21 | $6.94M derived: sum of 3 quarters · filed 2013-02-21 | |||||
| 2010-12-31 | $2.36M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $4.24M derived: sum of 2 quarters · filed 2013-02-21 | $7.50M 10-K · filed 2013-02-21 | |||||
| 2010-09-30 | $1.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $5.14M 10-Q · filed 2011-11-09 | ||||||
| 2010-06-30 | $3.25M 10-Q · filed 2011-08-12 | |||||||
| 2009-12-31 | $5.09M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |